Actively Recruiting
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
Led by University Hospital, Clermont-Ferrand · Updated on 2022-10-10
150
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.
CONDITIONS
Official Title
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 50 years or older with postmenopausal osteoporosis, fractured or not, needing anti-osteoporotic treatment
- Able to give informed consent to participate in the research
- Affiliated with a Social Security system
You will not qualify if you...
- Chronic kidney failure with glomerular filtration rate below 30 mL/min
- Medical or surgical history considered incompatible with the trial by the investigator
- Under legal protection or deprived of liberty
- Refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000
Actively Recruiting
Research Team
L
Lise LACLAUTRE
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here